Contact
Please use this form to send email to PR contact of this press release:
Principia Presents Consistent Positive Data of PRN1008 for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial
TO:
Please use this form to send email to PR contact of this press release:
Principia Presents Consistent Positive Data of PRN1008 for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial
TO: